Winthrop

Winthrop is the generic pharmaceutical division of Sanofi, primarily focused on the United States market. The company provides a broad portfolio of authorized generics and high-quality generic alternatives to branded medications across various therapeutic areas. Originally established as the Winthrop Chemical Company in 1919, it has a long history in the pharmaceutical industry, eventually becoming part of Sanofi through the acquisition of Sterling Winthrop. Winthrop leverages Sanofi's extensive manufacturing and quality control infrastructure to ensure the reliability of its products. Its offerings include treatments for cardiovascular diseases, central nervous system disorders, and anti-infectives. By focusing on affordability and accessibility, Winthrop plays a critical role in Sanofi's established medicines strategy.